2024. The Mitigating Role of Transresveratrol Against Doxorubicin-Induced Cardiotoxicity in Breast Cancer Patients via Modulating Mitochondrial Gene Expression: A Randomized Controlled Trial. Journal of Carcinogenesis. 23, 1 (Oct. 2024), 751–770. DOI:https://doi.org/10.64149/J.Carcinog.23.1.751-770.